These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 2285231)
1. Cytotoxic activity of azelaic acid against human melanoma primary cultures and established cell lines. Zaffaroni N; Villa R; Silvestro L; Sanfilippo O; Silvestrini R Anticancer Res; 1990; 10(6):1599-602. PubMed ID: 2285231 [TBL] [Abstract][Full Text] [Related]
2. [Effect of azelaic acid on the growth of melanoma cell cultures in comparison with fibroblast cultures]. Geier G; Hauschild T; Bauer R; Kreysel HW Hautarzt; 1986 Mar; 37(3):146-8. PubMed ID: 3700102 [TBL] [Abstract][Full Text] [Related]
3. Compared cytotoxicity effects of five anticancer drugs on human (HBL) and mouse (B16) melanoma cells in vitro. Arnould R; Dubois J; Abikhalil F; Libert A; Ghanem G; Atassi G; Hanocq M; Lejeune FJ Anticancer Res; 1990; 10(3):789-93. PubMed ID: 2369092 [TBL] [Abstract][Full Text] [Related]
4. Hyperpigmentary disorders--mechanisms of action. Effect of azelaic acid on melanoma and other tumoral cells in culture. Breathnach AS; Robins EJ; Nazzaro-Porro M; Passi S; Picardo M Acta Derm Venereol Suppl (Stockh); 1989; 143():62-6. PubMed ID: 2672685 [TBL] [Abstract][Full Text] [Related]
5. Azelaic acid: potential as a general antitumoural agent. Breathnach AS Med Hypotheses; 1999 Mar; 52(3):221-6. PubMed ID: 10362281 [TBL] [Abstract][Full Text] [Related]
6. Azelaic acid: mode of action at cellular and subcellular levels. Galhaup I Acta Derm Venereol Suppl (Stockh); 1989; 143():75-82. PubMed ID: 2475996 [TBL] [Abstract][Full Text] [Related]
7. Growth inhibitory effect of diheptyl diselenide on various human cancer cell lines. Scambia G; Panici PB; Battaglia F; Ferrandina G; Gaggini C; Mancuso S Anticancer Res; 1989; 9(6):1697-9. PubMed ID: 2627122 [TBL] [Abstract][Full Text] [Related]
8. Effect of dicarboxylic acids (C6 and C9) on human choroidal melanoma in cell culture. Breathnach AS; Robins EJ; Pätzold HC; Bhasin YP; Ethridge LB; Garner A; Nazzaro-Porro M Invest Ophthalmol Vis Sci; 1989 Mar; 30(3):491-8. PubMed ID: 2925320 [TBL] [Abstract][Full Text] [Related]
9. Anticancer drug sensitivity profiles of new and established melanoma cell lines. Marshall ES; Holdaway KM; Shaw JH; Finlay GJ; Matthews JH; Baguley BC Oncol Res; 1993; 5(8):301-9. PubMed ID: 8012062 [TBL] [Abstract][Full Text] [Related]
10. (R,R)-2,2'-[1,2-ethanediylbis[imino(1-methyl-2,1-ethanediyl)]]- bis[5-nitro-1H-benz[de]isoquinoline-1,3-(2H)-dione] dimethanesulfonate (DMP 840), a novel bis-naphthalimide with potent nonselective tumoricidal activity in vitro. Kirshenbaum MR; Chen SF; Behrens CH; Papp LM; Stafford MM; Sun JH; Behrens DL; Fredericks JR; Polkus ST; Sipple P Cancer Res; 1994 Apr; 54(8):2199-206. PubMed ID: 8174127 [TBL] [Abstract][Full Text] [Related]
11. Effect of dicarboxylic (C6 and C9) acids on a human squamous carcinoma cell line in culture. Pätzold HC; Breathnach AS; Robins EJ; Daridan ME; Bhasin YP; Ethridge LB; Nazzaro-Porro M; Passi S; Picardo M Histol Histopathol; 1989 Apr; 4(2):167-71. PubMed ID: 2520453 [TBL] [Abstract][Full Text] [Related]
12. Apoptosis induction by 4-nerolidylcatechol in melanoma cell lines. Brohem CA; Sawada TC; Massaro RR; Almeida RL; Rivelli DP; Ropke CD; da Silva VV; de Lima TM; Curi R; Barros SB; Maria-Engler SS Toxicol In Vitro; 2009 Feb; 23(1):111-9. PubMed ID: 19059332 [TBL] [Abstract][Full Text] [Related]
13. Cross-resistance and glutathione-S-transferase-pi levels among four human melanoma cell lines selected for alkylating agent resistance. Wang YY; Teicher BA; Shea TC; Holden SA; Rosbe KW; al-Achi A; Henner WD Cancer Res; 1989 Nov; 49(22):6185-92. PubMed ID: 2804968 [TBL] [Abstract][Full Text] [Related]
14. Antitumor efficiency of novel fluoro-substituted 6-amino-2-phenylbenzothiazole hydrochloride salts in vitro and in vivo. Stojkovic R; Karminski-Zamola G; Racane L; Tralic-Kulenovic V; Glavas-Obrovac L; Ivankovic S; Radacic M Methods Find Exp Clin Pharmacol; 2006; 28(6):347-54. PubMed ID: 16894403 [TBL] [Abstract][Full Text] [Related]
15. [The use of continuous cell cultures for the study of tumor heterogeneity and drug sensitivity]. Del Bufalo D; Cucco C; Leonetti C Medicina (Firenze); 1990; 10(3):298-302. PubMed ID: 1964194 [TBL] [Abstract][Full Text] [Related]
16. Effect of azelaic acid on melanoma cells in culture. Lemic-Stojcevic L; Nias AH; Breathnach AS Exp Dermatol; 1995 Apr; 4(2):79-81. PubMed ID: 7640879 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and anti-melanoma activity of analogues of N-acetyl-4-S-cysteaminylphenol substituted with two methyl groups alpha to the nitrogen. Lant NJ; McKeown P; Timoney MC; Kelland LR; Rogers PM; Robins DJ Anticancer Drug Des; 2001 Feb; 16(1):49-55. PubMed ID: 11762644 [TBL] [Abstract][Full Text] [Related]
18. Cytotoxic activity of fusaric acid on human adenocarcinoma cells in tissue culture. Fernandez-Pol JA; Klos DJ; Hamilton PD Anticancer Res; 1993; 13(1):57-64. PubMed ID: 8476229 [TBL] [Abstract][Full Text] [Related]
19. Effects of various antineoplastic agents on an established human melanoma cell line (G-361). García Reverte JM; Bernabeu Esclapez A; Muñoz Ramos J; Vicente Ortega V; Canteras Jordana M Histol Histopathol; 1995 Jan; 10(1):79-84. PubMed ID: 7756747 [TBL] [Abstract][Full Text] [Related]
20. Antitumor activity and mechanism of action of the novel marine natural products mycalamide-A and -B and onnamide. Burres NS; Clement JJ Cancer Res; 1989 Jun; 49(11):2935-40. PubMed ID: 2720652 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]